Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• The earliest identifiable hematopoietic progenitor in normal bone marrow is CD34+ MHC class II-.
• MHC class II antigen expression is maturation and lineage-dependent.
• CD34+DR- cells may be common precursors for stromal and hematopoietic elements, with CD34+DR+ being the earliest hematopoietic precursor.

Purpose of the Study:

• To investigate the role of MHC class II molecules in hematopoiesis.
• To understand the involvement of MHC class II in hematopoietic stem cell-stroma interactions.
• To explore the impact of anti-MHC class II antibodies on stem cell differentiation and survival.

Main Methods:

• Analysis of CD34+ MHC class II antigen expression on hematopoietic progenitors.
• Studies on embryonal cells to identify precursor populations.
• Investigation of MHC class II expression on stromal cells.
• Use of anti-MHC class II monoclonal antibodies (MABs) in stem cell proliferation/differentiation assays.
• Observation in allogeneic marrow transplant recipients and autologous models.

Main Results:

• MHC class II antigens are expressed in a maturation and lineage-dependent manner.
• DQ antigens are not expressed in cells with hematopoietic potential and are differentially regulated from DR and DP.
• MHC class II molecules are involved in hematopoietic cell-stroma interactions.
• Anti-MHC class II MABs can induce granulocytic differentiation and potentially interfere with long-term hematopoietic reconstitution.
• MHC class II molecules play a role in regulating hematopoiesis beyond histocompatibility.

Conclusions:

• MHC class II molecules are critical regulators of hematopoiesis, influencing stem cell differentiation and survival.
• These molecules are involved in cell-stroma interactions and have implications for hematopoietic reconstitution after transplantation.
• MHC class II molecules function as more than just histocompatibility markers in regulating blood cell formation.